MAZE vs QCOM · $525.3M cap vs P/E 16, rev $44.28B
Maze Therapeutics, Inc. Common Stock (MAZE) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
MAZE currently screens at market cap $525.3M. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the MAZE and QCOM stock pages for the full models.
Not investment advice.